<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells is generally restricted to the latent forms of <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Switching the latent form of <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> into the lytic form may induce <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>High levels of nuclear factor (NF)-kappaB can inhibit EBV lytic replication, and aspirin has the ability to inhibit NF-kappaB activity </plain></SENT>
<SENT sid="3" pm="."><plain>The aims of the current study were to determine the effects of aspirin on inducing EBV lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, and thus to reveal the possibility of targeting EBV-positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells by aspirin </plain></SENT>
<SENT sid="4" pm="."><plain>Our results showed that aspirin depleted NF-kappaB (p65) in the nucleus and reactivated EBV into lytic replication </plain></SENT>
<SENT sid="5" pm="."><plain>Cells exhibited decreased viability in a dose- and time-dependent manner when incubated with aspirin </plain></SENT>
<SENT sid="6" pm="."><plain>When <z:chebi fb="0" ids="465284">ganciclovir</z:chebi> was used in combination with aspirin to treat EBV-positive B95.8 cells and Raji cells, the cytotoxic effect of aspirin was amplified </plain></SENT>
<SENT sid="7" pm="."><plain>We demonstrated that aspirin reduced the viability of EBV-positive B lymphocytes due to its ability to induce EBV lytic replication </plain></SENT>
</text></document>